Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Ligand Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
72.31M 22.95M 45.01K 19.52M
Short-Term Investments
183.86M 147.35M 166.86K 321.59M
Long-Term Investments
10.91M 48.32M 3M n/a
Other Long-Term Assets
202.53M 5.92M 14.22M 23.25M
Receivables
42.45M 39.31M 35.04M 91.65M
Inventory
14.11M 23.97M 13.29M 27.33M
Other Current Assets
16.9M 2.66M 2.27M 4.67M
Total Current Assets
331.56M 237.43M 263.6M 464.75M
Property-Plant & Equipment
24.81M 25.06M 15.01M 32.75M
Goodwill & Intangibles
371.9M 470.27M 458.31M 745.11M
Total Long-Term Assets
610.22M 549.79M 499.07M 836.63M
Total Assets
941.77M 787.22M 762.67M 1.3B
Account Payables
5.23M 2.43M 5.31M 8.4M
Deferred Revenue
1.9M 1.22M 355K 11M
Short-Term Debt
1.29M n/a 76.69M n/a
Other Current Liabilities
-4.49M 8.04M 9.54M 25.32M
Total Current Liabilities
37.11M 16.78M 98.81M 41.66M
Long-Term Debt
n/a n/a n/a 320.72M
Other Long-Term Liabilities
35.88M 62.32M 25.38M 111.73M
Total Long-Term Liabilities
74.22M 69.52M 66.37M 438.09M
Total Liabilities
111.33M 86.3M 165.18M 479.75M
Total Debt
7.11M 6.17M 87.75M 336.26M
Common Stock
20K 18K 17.00 17K
Retained Earnings
498.98M 503.02M 450.86K 449.09M
Comprehensive Income
-5.94M -817K -984 -917K
Shareholders Equity
830.44M 700.91M 597.49M 821.63M
Total Investments
194.77M 195.68M 166.86K 321.59M